Skip to content

Validation of the novel 1-hour rule-in and rule-out troponin algorithm for diagnosis of non-ST-elevation myocardial infarction of the European Society of Cardiology

Validation of the novel 1-hour rule-in and rule-out troponin algorithm for diagnosis of non-ST-elevation myocardial infarction of the European Society of Cardiology

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00009713
Enrollment
2000
Registered
2015-12-07
Start date
2015-11-02
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I21

Interventions

Group 1: Patients presenting for rule-out of acute myocardial infarction by troponin testing at presentation and after one hour.

Sponsors

Universitäts-Herzzentrum Freiburg Bad Krozingen, Klinik für Kardiologie und Angiologie II
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients needing a rule-out of acute myocardial infarction due to: - acute chest pain or other symptoms equivalent with acute chest pain within the last 24 hours - new or presumably new ischaemic ECG changes - new or presumably new signs of ischaemia in imaging studies - available high-sensitivity cardiac troponin results at presentation and after 1 hour

Exclusion criteria

Exclusion criteria: - missing troponin results after 1 hour - chest pain lasting longer than 24 hours

Design outcomes

Primary

MeasureTime frame
Diagnosis of acute myocardial infarction according to Universal Definition of Myocardial Infarction: Detection of a rise and/or fall of cardiac biomarker values, (cardiac troponin) together with signs of ischaemia: clinical symptoms of ischaemia or new or presumed new significant ST-T wave changes or left bundle branch block on 12-lead ECG/development of pathological Q waves on ECG or imaging studies showing new or presumed new loss of viable myocardium or regional wall motion abnormality or intracoronary thrombus detected by angiography.

Secondary

MeasureTime frame
indication for coronary revascularization based on results of coronary angiography or clinical judgement.

Countries

Germany

Contacts

Public ContactWillibald Hochholzer

Universitäts-Herzzentrum Freiburg Bad Krozingen, Klinik für Kardiologie und Angiologie II

willibald.hochholzer@universitaets-herzzentrum.de+49 7633 402-0

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 20, 2026